Funding for this research was provided by:
Academy of Finland
Novo Nordisk UK Research Foundation
Signe ja Ane Gyllenbergin Säätiö
Samfundet Folkhälsan
Wilhelm och Else Stockmanns Stiftelse
Medicinska Understödsföreningen Liv och Hälsa
The Helsinki University Central Hospital Research Funds
Päivikki ja Sakari Sohlbergin Säätiö
Diabetes Wellness Finland
Article History
Received: 15 February 2018
Accepted: 9 May 2018
First Online: 18 May 2018
Compliance with ethical standards
:
: Professor Per-Henrik Groop has received research grants from Eli Lilly and Roche, is an advisory board member for AbbVie, Astra Zeneca, Boehringer-Ingelheim, Cebix, Eli Lilly, Janssen, MSD, Medscape, Novartis, Novo Nordisk, and Sanofi. He has received lecture honoraria from Astra Zeneca, Boehringer-Ingelheim, Eli Lilly, Elo Water, Genzyme, MSD, Novartis, Novo Nordisk, and Sanofi. All other authors declare no conflicts of interest.
: All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.